Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

DROVE EMOTIONALLY CHARGED ARGUMENTS TO GET PEOPLE TO VOTE AGAINST THEIR IN SANTA CRUZ COUNTY TWO COMPETEING AFFORABLE HOUSING MEASURES WERE ON BOTH MEASURE B AND C ARE TAX INITIATIVES AIMING TO FUND ...

An oft-mentioned advantage of ALGOL over FORTRAN is the recursion capability of the former. FORTRAN adherents often belittle this advantage by claiming that all recursive relations can be reduced to ...

Abstract: In this paper, we consider the array synthesis with low sidelobe level using two-way array factor (AF), which is defined as the product of the factors in transmit and receive AFs. Utilizing ...

The $12.5 million equity milestone payment is payable by Recursion pursuant to the previously announced agreement under which Rallybio sold its interest in the REV102 program to Recursion for up to ...

MOUNT PLEASANT, S.C. (WCBD) – WCBD News 2 has launched a Connected TV streaming app, WCBD+, offering live news, weather, and original programming – without a paid subscription. For more than 70 years, ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio ...

Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – The REV102 program originated from a joint venture ...